If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

FTSE 350 Low Yield News

FTSE 350 Low Yield

FTSE 350 Low Yield (LIX) Index Information
Index Value: 6,011.91
Change:  18.77 (0.31%)
Open: 5,993.52
High: 6,024.38
Low: 5,993.52
Yest. Close: 5,993.14014
FTSE 350 Low Yield Live PriceLast checked at -
IN BRIEF: Plus500 starts new USD100 million share buyback
16 Feb 2026

IN BRIEF: Plus500 starts new USD100 million share buyback

Plus500 Ltd - Haifa, Israel-based trading platform operator - Starts on Monday a new share buyback programme worth up to USD100 million. The buyback w...

LONDON MARKET OPEN: FTSE 100 green, Helium One climbs after flow tests
16 Feb 2026

LONDON MARKET OPEN: FTSE 100 green, Helium One climbs after flow tests

(Alliance News) - Stock prices in London opened higher on Monday, as Iran's foreign minister arrives in Geneva ahead of a second round of negotiations...

Helium One + 3 more shares
LONDON BRIEFING: NatWest starts buyback, Pebble Beach wins contract
16 Feb 2026

LONDON BRIEFING: NatWest starts buyback, Pebble Beach wins contract

(Alliance News) - The FTSE 100 was called higher on Monday, as Beazley extends its deadline for Zurich Insurance to make an acquisition offer.

Unilever + 5 more shares
Beazley extends 'put up or shut up' deadline as Zurich due diligence progresses
16 Feb 2026

Beazley extends 'put up or shut up' deadline as Zurich due diligence progresses

(Sharecast News) - Beazley said on Monday that the deadline for Zurich Insurance to make a firm takeover bid has been extended.

Take Five: Giddy Up
16 Feb 2026

Take Five: Giddy Up

Feb 13 (Reuters) - Much of Asia will be off to celebrate the ​Lunar New Year ⁠as the year of the fire horse begins, a rare combination said to pair el...

Walmart + 7 more shares
Hunting hails 'excellent' pilot results as Buccaneer wells double output
16 Feb 2026

Hunting hails 'excellent' pilot results as Buccaneer wells double output

(Sharecast News) - Precision engineering group Hunting said on Monday that it had received positive results from a pilot test of its enhanced oil reco...

UK property asking prices hold steady after post-budget jump, Rightmove says
16 Feb 2026

UK property asking prices hold steady after post-budget jump, Rightmove says

LONDON, Feb 16 (Reuters) - Asking prices ​for ⁠British homes held steady in ​the four weeks to February 7 after a post-budget relief rally ​over ‌the ...

Dauch profit down on Dowlais deal costs, hails "transformational" buy
13 Feb 2026

Dauch profit down on Dowlais deal costs, hails "transformational" buy

(Alliance News) - Dauch Corp on Friday reported a wider fourth quarter loss and a decline in annual profit, stemming from costs related to its buy of ...

Dauch Corp + 1 more share
United's stalled A350 order thrown into doubt by Rolls-Royce engine row
13 Feb 2026

United's stalled A350 order thrown into doubt by Rolls-Royce engine row

CHICAGO, Feb 13 (Reuters) - United Airlines has injected new uncertainty into its long-delayed Airbus A350 order after disclosing a dispute with engin...

United Airlines Holdings + 3 more shares
LONDON MARKET CLOSE: FTSE 100 closes green, UK plans big missile spend
13 Feb 2026

LONDON MARKET CLOSE: FTSE 100 closes green, UK plans big missile spend

(Alliance News) - Stock prices in London closed mostly higher on Friday, following the news that US consumer inflation slowed more than expected last ...

Natwest + 12 more shares
IN BRIEF: Prudential chair-designate Flint to join insurer on March 4
13 Feb 2026

IN BRIEF: Prudential chair-designate Flint to join insurer on March 4

Prudential PLC - London-based insurer - Confirms Douglas Flint's appointment as a non-executive director and chair-designate will become effective on ...

Prudential + 3 more shares
Shore Capital lowers AstraZeneca to 'hold'
13 Feb 2026

Shore Capital lowers AstraZeneca to 'hold'

(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings out...